XML 68 R53.htm IDEA: XBRL DOCUMENT v3.26.1
Consolidated Financial Statements Details - Accrued and Other Liabilities (Details) - USD ($)
$ in Thousands
Dec. 31, 2025
Dec. 31, 2024
Accrued and other liabilities    
Share-based liability $ 3,197  
Accrued short-term interest payable 2,777 $ 3,039
Accrued legal and accounting fees 1,765 251
Accrued incentive compensation 1,645 1,555
Accrued payroll and benefits 394 170
Accrued clinical liabilities   306
Income taxes payable in connection with Pulmokine acquisition   280
Other accrued liabilities 107 151
Total $ 9,885 $ 5,752